Material Change Report

Name and Address of Company

Mind Medicine (MindMed) Inc. (the "Company")

1166 Alberni Street, Suite 1604,

Vancouver, British Columbia

V6E 3Z

Date of Material Change

September 29, 2021

News Release

On September 30, 2021, a news release was disseminated through the newswire services of GlobalNewswire and subsequently filed on SEDAR at www.sedar.com.

Summary of Material Change

On September 29, 2021, the Company appointed Andreas Krebs and Carol Vallone as directors of the Company and Bruce Linton ceased to be a director of the Company.

Full Description of Material Change
5.1 Full Description of Material Change

On September 29, 2021, the Company appointed Andreas Krebs and Carol Vallone as directors of the Company and Bruce Linton ceased to be a director of the Company.

5.2 Disclosure for Restructuring Transactions

Not Applicable.

Reliance on subsection 7.1(2) of National Instrument 51-102

Not Applicable.

Omitted Information

Not Applicable.

Executive Officer

For further information, please contact Rob Barrow, Chief Executive Officer of the Company, at 212-220-6633.

Date of Report

October 4, 2021.

Attachments

  • Original document
  • Permalink

Disclaimer

Mind Medicine (MindMed) Inc. published this content on 04 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 October 2021 20:44:12 UTC.